Acute Myelogenous Leukemia

Table of Contents

1. Altmetric Badge
   Book Overview
2. Altmetric Badge
   Chapter 1 Approaching the Treatment of AML from a Biological Perspective
3. Altmetric Badge
   Chapter 2 Aberrant Transcription Factors in AML
4. Altmetric Badge
   Chapter 3 Myelodysplasia-Related AML
5. Altmetric Badge
   Chapter 4 Therapy-related AML
6. Altmetric Badge
   Chapter 5 The DNA Damage Response, DNA Repair, and AML
7. Altmetric Badge
   Chapter 6 Altered Apoptosis in AML
8. Altmetric Badge
   Chapter 7 Drug Resistance Transporters in AML
9. Altmetric Badge
   Chapter 8 Impact of Cytogenetics on Clinical Outcome in AML
10. Altmetric Badge
    Chapter 9 APL: A Classic Tale of Bench to Bedside
11. Altmetric Badge
    Chapter 10 Emerging Therapeutics for AML
12. Altmetric Badge
    Chapter 11 FLT3: A Prototype Receptor Tyrosine Kinase Target in AML
13. Altmetric Badge
    Chapter 12 Farnesyl Transferase Inhibitors in the Therapy of AML
14. Altmetric Badge
    Chapter 13 Modulating Gene Expression as a Therapeutic Approach in the Treatment of AML
15. Altmetric Badge
    Chapter 14 Differentiation Therapy in AML
16. Altmetric Badge
    Chapter 15 Stem Cell Transplantation for AML
17. Altmetric Badge
    Chapter 16 Tumor Vaccines in Leukemia
18. Altmetric Badge
    Chapter 17 Treatment, Outcomes, and Challenges of Newly Diagnosed AML in Children and Adolescents
19. Altmetric Badge
    Chapter 18 AML in Older Adults
20. Altmetric Badge
    Chapter 19 Dameshek Smiles: Molecular Clues to the Chronic Myeloproliferative Disorders Unmasked
21. Altmetric Badge
    Chapter 20 New Designs for Clinical Trials